|
Archive 2014: speakers
2014 | 2015 | 2016 | 2017
Post-release | Programme | Speakers | Sponsors

|
JULYA BELOVA,
Head of Marketing communications an Innovations, Takeda Pharmaceuticals
|

|
VLADIMIR BOIKO,
Commercial Director Russia & CIS, MSD
|

|
EVGENIA EYRAMDJANTS,
Head of syndicated research pharmaceutical and medical markets, GfK Rus
|

|
IVAN GLUSHKOV,
Head of Development, Stada CIS
|

|
GERMAN INOZEMTSEV,
Head of Strategy and Business Development, Synovate Comcon
|

|
IGOR KLIMANOV,
Head of Marketing and Sales, NPO Petrovax Pharm
|

|
OKSANA KRASNYH,
Head of Consumer Marketing, Materia Medica Holding
|

|
IGOR KRYLOV,
CEO, Pharmstandard
|

|
URIY LITVITCHENKO,
CEO, Chiesi Russia
|

|
SERGEY MASTYAGIN,
Innovative Channels Development Manager, Astrazeneca Russia
|

|
DAVID MELIK-GUSEINOV,
Director, Social Economics Centre
|

|
TIMOFEY NIZHEGORODTSEV,
Head of Department for control of social sphere and commerce, Federal Antimonopoly Service
|

|
LEONID PARSHENKOV,
General Director, Abbott Russia
Leonid Parshenkov has more than 15 years experience in the Russian healthcare industry. During this period he has gained profound expertise in the areas of sales, marketing and management.
From 2006 till 2010, Leonid served as Director at Solvay Pharmaceuticals, Russia. Under his management the company won a number of prestigious awards in healthcare, including Platinum Ounce Awards for “Best Project” (Solyaris) in 2007 and “Best Educational Project” (Pharmacy Program) in 2006.
Following the acquisition of Solvay Pharmaceuticals by Abbott in 2010, Leonid was appointed to the position of General Director at Abbott Russia. Under his management the company recently received Platinum Ounce Awards in “Dynamic of the Year” nomination for significant growth in 2011, and “Project of the Year” for Star Brush, art contest for children with cystic fibrosis, in 2013.
Leonid Parshenkov received a degree in general surgery from Krasnodar Medical Institute. He later received an MBA from EMBA Antwerp Management School.
|
 |

|
SERGEY PATRAKEEV,
Consultant, Co-Head of Pharmaceutical Practice, Lidings
Education
- State University of Kaliningrad, Russia
- University of Göttingen, Germany, LL.M. (M. jur.)
- Max Planck Institute, Heidelberg, Germany, PhD candidate
Professional experience
Sergey Patrakeev is a Counsel in Lidings’ Corporate and M&A practice and Co-Head of Pharmaceuticals Industry practice in the firm’s Moscow office. Sergey specializes in advising foreign business on all aspects of corporate law. His expertise covers comprehensive legal support of daily business activities of the pharmaceutical companies including interactions with state authorities, contractual work, interactions with medical representatives, tax and customs regulation, compliance, and dispute resolution matters. The 2013 edition of a prominent international directory The Legal 500 EMEA recognizes Sergey Patrakeev as “very knowledgeable in matters relating to the pharmaceuticals industry”.
|
 |

|
ANDREY POTAPOV,
CEO, Takeda Pharmaceuticals Russia - CIS
|

|
VIKTOR PUSHKAREV,
Regional Director, CIS ORION PHARMA
|

|
STANISLAV RESHETNIKOV,
Head of OTC drugs marketing, Pharmstandard
|

|
ALEXANDER SEMENOV,
CEO, «First Aid»
|

|
ALEKSANDR SITNIKOV,
Managing Partner, VEGAS LEX
|

|
VITALIY SMERDOV,
CEO, Pharmaceutical company ”Sotex”
|

|
NIKOLAY SOLOVIEV,
CEO, UNIPHARM
|

|
VLADIMIR SHIPKOV,
Executive Director, AIPM
Education:
- 1974 — Military Institute of Foreign Languages.
- 1991 — Russian State Humanities University.
Professional activity
For a long time Mr. Shipkov has worked in the different governmental institutions. He has a deep knowledge and understanding of governmental functioning, as well as a wide range of contacts that contribute to the execution of the assigned duties in AIPM. His career of the government employee includes, among other, the functions of the Director of Pharmaceutical Inspection of the Ministry of Healthcare of the Russian Federation, Deputy Director of the Federal Service of Intellectual Property, Patents and Trademarks (Russian Agency for Patents and Trademarks). Mr. Shipkov also has working experience in the State Duma of the Russian Federation, State Customs Committee of the Russian Federation, banking sector. He served on actual military service.
Since 2007 he is heading of the Association of International Pharmaceutical Manufacturers.
|
 |

|
SERGEY SHULIAK,
CEO, DSM Group
Education
- Pirogov Russian Medical University, Moscow, Russia, Doctor Pediatrician Resuscitator.
- Lomonosov Moscow State University, Moscow, Russia, Organizational Psychology, Physiologist.
Experience
- 1990–1995
Russian Children's Clinical Hospital, Doctor Pediatrician Resuscitator.
- 1995–1998 IMS Health, Russian representative office, Chief of Data Source.
- 1999–2009
JSC “DSM Group”, Marketing Director.
- 2009 – present — JSC “DSM Group”, General Director.
The Founder of the JSC "DSM Group" company. Expert of the pharmaceutical market of Russia and CIS countries. Member of coordination council "Russian Association of Pharmaceutical Marketing". He delivers lectures on marketing and psychology.
«DSM Group» has been on the market since 1999. The agency offers a unique opportunity to use Retail Audit, Hospital, DLO Audit data in the CIS countries (Russia, Ukraine, Kazakhstan, Belarus, Moldova and others) to its clients for their daily work. A distinctive feature of «DSM Group» Databases is data updating rate and data accuracy as well. The procedure of the Retail Audit processing meets ISO 9001:2008 requirements. DSM Group also provides the range of marketing services regularly, analyzes market capacity and trends reporting them in newspapers and business magazines, carries out surveys of pharmacists and doctors, carries out focus groups, conducts custom researches and provides advertising support as well. Our clients are world leaders in manufacturing drugs (medicines). Our data is used in Ministries and Departments. Since 1999 DSM Group has been a member of the ESOMAR, world association for market, social and opinion researchers.
|

|
DMITRY SHUROV,
Strategic Planning & Commercial Solutions Director, Pfizer
|

|
ALEXEY TORGOV,
Deputy CEO for GR, BIOCAD
|

|
MARINA VELDANOVA,
CEO, Ipsen
|

|
OLEG FELDMAN,
Head of healthcare, Synovate Comcon Healthcare
|

|
NIKOLAY ZHAVORONKOV,
Deputy CEO, Jadran
|
|
|
|
|